Search references for OLORINAB. Phrases containing OLORINAB
See searches and references containing OLORINAB!OLORINAB
Chemical compound
Olorinab (APD371) is a drug being developed by Arena Pharmaceuticals for the treatment of gastrointestinal pain associated with Crohn's disease and irritable
Olorinab
Psychoactive drug from the cannabis plant
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Cannabis_(drug)
Medication for pain and fever
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Paracetamol
Phytocannabinoid discovered in 1940
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Cannabidiol
Genus of flowering plants
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Cannabis
– CB1 and CB2 receptor agonist NEO-1940 – CB1 and CB2 receptor agonist Olorinab (APD-371) – CB2 receptor agonist Fasinumab (REGN-475, SAR-164877) – monoclonal
List of investigational analgesics
List_of_investigational_analgesics
Psychoactive component of cannabis
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Tetrahydrocannabinol
Species of plant
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Cannabis_ruderalis
Pharmaceutical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
ART26.12
Plant species
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Cannabis_sativa
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
List_of_cannabinoids
Species of plant
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Cannabis_indica
Natural bicyclic sesquiterpene
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Caryophyllene
Chemical compound
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Palmitoylethanolamide
Biological system of neurotransmitters
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Endocannabinoid_system
Specific cannabis extract
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Nabiximols
Homologue of tetrahydrocannabinol
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Tetrahydrocannabivarin
Group of receptors to cannabinoid compounds
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Cannabinoid_receptor
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Etrinabdione
Mammalian protein found in humans
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Cannabinoid_receptor_1
Drug designed to treat obesity
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Orlistat
Compounds found in cannabis
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Cannabinoid
Synthesis of THC from CBD
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Conversion_of_CBD_to_THC
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
AM-2201
Chemical compound
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Honokiol
Chemical compound
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Zevaquenabant
Isomer of tetrahydrocannabinol
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Δ8-Tetrahydrocannabinol
Proposed mechanism of cannabis compounds
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Entourage_effect
Cannabinoid agonist compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Tetrahydrocannabiphorol
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Cannabichromene
Chemical compound
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Kaempferol
Acetate ester of tetrahydrocannabinol (THC)
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
THC-O-acetate
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Effects_of_cannabis
Chemical compound
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Genistein
Minor cannabinoid
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Cannabigerol
Medication and supplement
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Pregnenolone_(medication)
Species of plant
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Kava
THC precursor
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Tetrahydrocannabinolic_acid
Chemical compound (fatty acid neurotransmitter)
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Anandamide
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Rimonabant
Pharmaceutical compound
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
ONO-1110
Designer drugs
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Synthetic_cannabinoids
Chemical compound
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Monlunabant
Cannabis sativa L. (marijuana; hemp) used medicinally
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Medical_cannabis
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
WIN_55,212-2
Chemical compound
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Epicatechin_gallate
Compound binding to cannabinoid receptors
of other cannabinoid receptor modulators are also under investigations. Olorinab, Ajulemic acid, NTRX-07 and CNTX-6016 are examples of the new cannabinoid
Cannabinoid receptor modulator
Cannabinoid_receptor_modulator
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Long-term_effects_of_cannabis
Naturally-occurring cannabinoid
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Cannabinol
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
JWH-073
Synthetic cannabinoid
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
HU-210
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Oleamide
Active metabolite of Δ9-THC
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
11-Hydroxy-THC
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
MDMB-4en-PINACA
Semi-sythetic cannabinoid drug
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Hexahydrocannabiphorol
Pharmaceutical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Dronabinol/palmidrol
Chemical compound
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Oleoylethanolamide
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
ADB-BUTINACA
Synthetic cannabinoid
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Nabilone
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
JWH-018
Class of enzymes
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Monoacylglycerol_lipase
Pharmaceutical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Irafamdastat
Chemical compound
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Yangonin
Pharmaceutical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Tetrahydrocannabinol/cannabinol/cannabidiol
Tetrahydrocannabinol/cannabinol/cannabidiol
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Endocannabinoid_transporter
Chemical compound
compounds are known, most of which also show high CB2 selectivity. CBS-0550 Olorinab SER-601 Glenmark’s Molecule for Neuropathic Pain, Osteoarthritis - GRC
Tedalinab
Pharmaceutical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Z8526711350
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Levonantradol
Mammalian protein found in Homo sapiens
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Fatty-acid_amide_hydrolase_1
Isomer of tetrahydrocannabinol
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Δ11-Tetrahydrocannabinol
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
AB-CHMINACA
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
JWH-007
Endocannabinoid reuptake inhibitor under development for psychiatric disorders
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
SYT-510
Chemical compound
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
JD5037
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Lenabasum
Pharmaceutical compound
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
WOBE437
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
NNE1
Chemical compound
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Gallocatechol
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Dimethylheptylpyran
Chemical compound
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Magnolol
Synthetic chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Cod-THC
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
ADB-5'Br-BUTINACA
Synthetic cannabinoid
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
THJ-2201
Phytocannabinoid compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Isotetrahydrocannabinol
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
AB-PINACA
Chemical compound
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Pregnenolone
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Cannabicyclohexanol
Cis enantiomer of tetrahydrocannabidiol
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Cis-THC
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
A-PONASA
Compounds that inhibit or block the activity of cannabinoid receptors
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
Cannabinoid receptor antagonist
Cannabinoid_receptor_antagonist
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
AM-251_(drug)
Working on the endocannabinoid neurotransmitters
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Cannabinoidergic
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
5F-APINACA
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
AMB-FUBINACA
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
APICA (synthetic cannabinoid drug)
APICA_(synthetic_cannabinoid_drug)
Main secondary metabolite of THC
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
11-Nor-9-carboxy-THC
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
MDMB-5'Br-BUTINACA
Chemical compound
MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602 O-2220 O-889 Olorinab PF-03550096 PSB-SB-1202 PTI-1 PTI-2 PTI-3 QMPSB S-444,823 S-777,469 SER-601
JWH-133
Chemical compound
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
Biochanin_A
Protein-coding gene in the species Homo sapiens
L-759,633 L-759,656 Lenabasum (anabasum) Magnolol MDA-19 Nabitan NADA Olorinab (APD-371) PF-03550096 S-444,823 SER-601 Serinolamide A UR-144 Tedalinab
GPR55
OLORINAB
OLORINAB
OLORINAB
OLORINAB
OLORINAB
OLORINAB
OLORINAB
OLORINAB
OLORINAB